October 14, 2015
Weill Cornell profiles the Tri-I TDI in the October issue of Weill Cornell Medicine
Read, “On the Fast Track”, by Heather Salerno
- September 9, 2014 The Weill Cornell Medical College presents the MILSTEIN PROGRAM IN MEDICINAL CHEMISTRY SYMPOSIUM: FROM TARGET TO TREATMENT
- October 1, 2013 Tri-Institutional Therapeutics Discovery Institute, Inc. Launched by Memorial Sloan-Kettering Cancer Center, The Rockefeller University and Weill Cornell Medical College, and Partnership Formed with Takeda
A global, research-based pharmaceutical company with a strong record for bringing new medicines to market, Takeda will provide medicinal chemists and pharmacologists to work on the development of small molecules.